McKesson Corporation (MCK) Stock Price

MCKStockS&P 500

$1004.84+29.58%52W

Market Cap$117.15B

P/E24.60x

PEG Ratio1.89

Div yield0.54%

Beta0.30

MCK Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)6.56%

Price vs S&P 500 (4W)14.68%

PEG Ratio1.89

VGM Score59.27

P/E Ratio (Annual)24.60x

Indicated Dividend Yield (Annual)0.54%

P/CF (Annual)19.03x

Book Value / Share (Quarterly)$36.58

P/TBV (Annual)11.28x

Indicated Dividend (Annual)$3.76

Revenue Growth (3Y)13.39%

Cash Flow / Share (Quarterly)$52.97

Payout Ratio (TTM)8.56%

Price vs S&P 500 (YTD)10.57%

Gross Margin (TTM)3.64%

Net Profit Margin (TTM)1.12%

EPS (TTM)$37.35

10-Day Avg Trading Volume0.69M

EPS Excl Extra (TTM)$37.35

Revenue Growth (5Y)11.11%

EPS (Annual)$38.37

Dividend / Share (Annual)$3.11

ROI (Annual)7.21%

Gross Margin (Annual)3.60%

Net Profit Margin (5Y Avg)0.96%

Cash / Share (Quarterly)$44.52

P/E Basic Excl Extra (TTM)25.51x

Revenue Growth QoQ (YoY)7.72%

EPS Growth (5Y)39.07%

P/E Normalized (Annual)24.60x

ROA (Last FY)5.78%

Revenue Growth TTM (YoY)8.84%

EBITD / Share (TTM)$55.14

ROE (5Y Avg)17.95%

Operating Margin (TTM)1.58%

Cash Flow / Share (Annual)$45.08

P/B Ratio19.89x

P/B Ratio (Quarterly)4.06x

Net Income / Employee (Annual)$110,700

EV / Revenue (TTM)0.30x

Net Interest Coverage (TTM)1551.25x

ROA (TTM)5.42%

EPS Growth QoQ (YoY)-17.54%

EV / EBITDA (TTM)18.01x

EPS Incl Extra (Annual)$38.37

Current Ratio (Annual)0.85x

Quick Ratio (Quarterly)0.51x

3-Month Avg Trading Volume0.96M

52-Week Price Return29.58%

EV / Free Cash Flow (Annual)22.50x

P/E Incl Extra (TTM)25.51x

Revenue / Employee (TTM)$9,557,700

Tangible BV / Share (Quarterly)$17.76

P/S Ratio (Annual)0.29x

Asset Turnover (Annual)4.90x

52-Week High$1014.99

Operating Margin (5Y Avg)1.26%

EPS Excl Extra (Annual)$38.37

CapEx CAGR (5Y)3.05%

Tangible BV CAGR (5Y)-15.75%

26-Week Price Return16.46%

Quick Ratio (Annual)0.48x

13-Week Price Return19.43%

Total Debt / Equity (Annual)1.45x

Current Ratio (Quarterly)0.89x

Enterprise Value$121.72B

Revenue / Share Growth (5Y)16.99%

Asset Turnover (TTM)4.85x

Book Value / Share Growth (5Y)-1.84%

Revenue / Employee (Annual)$9,382,100

Inventory Turnover (Annual)16.48x

Pretax Margin (Annual)1.54%

Cash / Share (Annual)$33.13

3-Month Return Std Dev29.85%

Gross Margin (5Y Avg)4.15%

Net Income / Employee (TTM)$106,800

EBITDA CAGR (5Y)9.08%

EBITDA Interim CAGR (5Y)16.46%

ROE (Last FY)17.67%

Net Interest Coverage (Annual)29.83x

EPS Basic Excl Extra (Annual)$38.37

P/FCF (TTM)17.98x

Receivables Turnover (TTM)14.06x

EV / Free Cash Flow (TTM)19.81x

Total Debt / Equity (Quarterly)1.29x

EPS Incl Extra (TTM)$37.35

Receivables Turnover (Annual)17.63x

ROI (TTM)16.23%

Dividend Growth Rate (5Y)12.51%

P/S Ratio (TTM)0.29x

Pretax Margin (5Y Avg)1.28%

Revenue / Share (Annual)$3250.85

Tangible BV / Share (Annual)$11.95

Forward P/E18.80x

Free OCF CAGR (5Y)6.76%

Price vs S&P 500 (52W)14.05%

P/E Ratio (TTM)25.51x

EPS Growth TTM (YoY)49.07%

Year-to-Date Return22.50%

5-Day Price Return5.14%

EPS Normalized (Annual)$38.37

ROA (5Y Avg)4.42%

Net Profit Margin (Annual)1.18%

Month-to-Date Return17.69%

Cash Flow / Share (TTM)$31.05

EBITD / Share (Annual)$52.12

EPS Growth (3Y)15.30%

Operating Margin (Annual)1.54%

LT Debt / Equity (Annual)1.21x

P/CF (TTM)17.10x

ROI (5Y Avg)9.37%

P/E Excl Extra (TTM)25.51x

LT Debt / Equity (Quarterly)0.99x

EPS Basic Excl Extra (TTM)$37.35

P/TBV (Quarterly)8.36x

Payout Ratio (Annual)8.00%

P/B Ratio (Annual)4.29x

Dividend / Share (TTM)$3.26

Inventory Turnover (TTM)15.43x

Pretax Margin (TTM)1.57%

Book Value / Share (Annual)$31.43

Price vs S&P 500 (13W)16.74%

Net Margin Growth (5Y)18.73%

Dividend Yield (TTM)0.34%

Beta0.30x

P/FCF (Annual)21.66x

Revenue / Share (TTM)$3447.84

ROE (TTM)39.43%

52-Week Low$723.68

vGradeD

gGradeB

mGradeB

vgmGradeC

MCK Earnings Surprise History

Quarter	Report date	EPS estimate	EPS actual	Surprise
Q2 2026	Aug 5, 2026	$9.54	$9.93	+4.14%(+$0.39)
Q1 2026	May 7, 2026	$11.57	$11.69	+1.06%(+$0.12)
Q4 2025	Feb 4, 2026	$9.27	$9.34	+0.71%(+$0.07)
Q3 2025	Nov 5, 2025	$9.05	$9.86	+8.94%(+$0.81)
Q2 2025	Aug 6, 2025	$8.15	$8.26	+1.39%(+$0.11)

MCK Analyst Recommendations

Jun 2026

Jul 2026

Aug 2026

Sep 2026

4.26

4.13

Industry Peers — Drug Wholesale(11)

Symbol	Value Score	Growth Score	Momentum Score	P/E Ratio (Annual)	ROE (TTM)	Operating Margin (TTM)	Revenue Growth TTM (YoY)	Price
MCKMcKesson Corporation	D	B	B	24.6x	39.4%	1.6%	8.8%	$1004.84
CORCencora, Inc.	D	B	B	41.9x	106.4%	0.9%	5.1%	$340.92
CAHCardinal Health, Inc.	D	B	A	34.3x	37.2%	1.0%	14.2%	$254.06
HLFHerbalife Ltd.	B	D	A	6.7x	170.7%	-14.1%	5.5%	$14.60
NUSNuSkin Enterprises, Inc.	B	F	C	1.6x	-29.4%	-0.8%	-15.4%	$5.14
WGRXWellgistics Health, Inc. Common Stock	D	F	D	—	-1645.9%	-506.9%	-51.6%	$4.28
ZSTKZeroStack Corp. Common Stock	—	D	C	—	-382.3%	-595.2%	—	$4.00
ESYNEnerSyn Global Inc. Common Stock	—	—	C	—	—	—	—	$1.94
COSMCosmos Holdings Inc. Common Stock	D	B	C	—	-118.9%	-24.8%	33.8%	$0.33
HWHHWH International Inc. Common Stock	F	D	B	—	-103.9%	-716.1%	-68.5%	$1.98
MEDSDataMeds AI, Inc. Common Stock	D	D	D	—	-1645.9%	-1034.0%	-78.2%	$2.63
HKPDCellyan Biotechnology Co., Ltd Class A Ordinary Shares	—	F	F	—	—	—	—	$0.11

About McKesson Corporation

McKesson Corp is one of three dominant pharmaceutical wholesalers in the United States, controlling a significant portion of the pharmaceutical distribution market alongside Cencora and Cardinal Health. The company sources and distributes branded, generic, and specialty pharmaceuticals to retail pharmacies, independent pharmacies, hospitals, and healthcare providers, while also supplying medical-surgical products and equipment to healthcare facilities. McKesson maintains operations in Canada for pharmaceutical distribution and offers technology solutions to pharmacy customers.